JENNIFER URENA: Open Payments
NPI 1740512078 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 12 payments from 11 companies in 2025. Trend: 2023 $727 · 2024 $199 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $133 |
| Astellas Pharma US Inc | 1 | $98 |
| COLOPLAST CORP | 1 | $91 |
| Teva Pharmaceuticals USA, Inc. | 1 | $87 |
| Janssen Biotech, Inc. | 1 | $69 |
| ABBVIE INC. | 2 | $57 |
| Procept Biorobotics Corporation | 1 | $38 |
| UROGEN PHARMA, INC. | 1 | $27 |
| Teleflex LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: Axonics, Xtandi, Altis, AUSTEDO XR, RYBREVANT, BOTOX, AQUABEAM ROBOTIC SYSTEM, UROLIFT.
Industry payments across NV — which companies pay providers there.
